Peak Retirement Planning, Inc. Incyte Corp Transaction History

Peak Retirement Planning, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Nov 04, 2025	SELL	$55.17 - $71.22 $858,776 - $1.11 Million	-15,566 Closed	0 $0
Q1 2025 Nov 04, 2025	BUY	$60.0 - $75.26 $115,680 - $145,101	1,928 Added 14.14%	15,566 $943 Million
Q4 2024 Feb 20, 2025	BUY	$65.08 - $83.38 $887,561 - $1.14 Million	13,638 New	13,638 $921 Million

811

205M

638K

635K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $23.2B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Peak Retirement Planning, Inc., based on Form 13F filings with the SEC.

Stay updated on Peak Retirement Planning, Inc. with notifications on news.